Titre : Hypoglycémiants

Hypoglycémiants : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hypoglycémiants : Questions médicales les plus fréquentes", "headline": "Hypoglycémiants : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hypoglycémiants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-16", "dateModified": "2025-03-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hypoglycémiants" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Effets physiologiques des médicaments", "url": "https://questionsmedicales.fr/mesh/D045505", "about": { "@type": "MedicalCondition", "name": "Effets physiologiques des médicaments", "code": { "@type": "MedicalCode", "code": "D045505", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des glycoside hydrolases", "alternateName": "Glycoside Hydrolase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065089", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des glycoside hydrolases", "code": { "@type": "MedicalCode", "code": "D065089", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.249" } } }, { "@type": "MedicalWebPage", "name": "Agonistes des récepteurs de l'amyline", "alternateName": "Amylin Receptor Agonists", "url": "https://questionsmedicales.fr/mesh/D065091", "about": { "@type": "MedicalCondition", "name": "Agonistes des récepteurs de l'amyline", "code": { "@type": "MedicalCode", "code": "D065091", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.374" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la dipeptidyl-peptidase IV", "alternateName": "Dipeptidyl-Peptidase IV Inhibitors", "url": "https://questionsmedicales.fr/mesh/D054873", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la dipeptidyl-peptidase IV", "code": { "@type": "MedicalCode", "code": "D054873", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.500" } } }, { "@type": "MedicalWebPage", "name": "Secrétagogues à l'insuline", "alternateName": "Insulin Secretagogues", "url": "https://questionsmedicales.fr/mesh/D000092005", "about": { "@type": "MedicalCondition", "name": "Secrétagogues à l'insuline", "code": { "@type": "MedicalCode", "code": "D000092005", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.625" } } }, { "@type": "MedicalWebPage", "name": "Agonistes du PPAR gamma", "alternateName": "PPAR-gamma Agonists", "url": "https://questionsmedicales.fr/mesh/D000092126", "about": { "@type": "MedicalCondition", "name": "Agonistes du PPAR gamma", "code": { "@type": "MedicalCode", "code": "D000092126", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.688" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cotransporteur sodium-glucose de type 2", "alternateName": "Sodium-Glucose Transporter 2 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000077203", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cotransporteur sodium-glucose de type 2", "code": { "@type": "MedicalCode", "code": "D000077203", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Hypoglycémiants", "alternateName": "Hypoglycemic Agents", "code": { "@type": "MedicalCode", "code": "D007004", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nunzio Cardullo", "url": "https://questionsmedicales.fr/author/Nunzio%20Cardullo", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Giuseppe Floresta", "url": "https://questionsmedicales.fr/author/Giuseppe%20Floresta", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Vera Muccilli", "url": "https://questionsmedicales.fr/author/Vera%20Muccilli", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Antonio Rescifina", "url": "https://questionsmedicales.fr/author/Antonio%20Rescifina", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Corrado Tringali", "url": "https://questionsmedicales.fr/author/Corrado%20Tringali", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35916049", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3346/jkms.2022.37.e241" } }, { "@type": "ScholarlyArticle", "name": "[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].", "datePublished": "2022-10-07", "url": "https://questionsmedicales.fr/article/36205744", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00120-022-01945-x" } }, { "@type": "ScholarlyArticle", "name": "[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36427493", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1902-6326" } }, { "@type": "ScholarlyArticle", "name": "Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.", "datePublished": "2023-06-14", "url": "https://questionsmedicales.fr/article/37316688", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10995-023-03732-2" } }, { "@type": "ScholarlyArticle", "name": "Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/37543936", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.34172/aim.2023.22" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Effets physiologiques des médicaments", "item": "https://questionsmedicales.fr/mesh/D045505" }, { "@type": "ListItem", "position": 5, "name": "Hypoglycémiants", "item": "https://questionsmedicales.fr/mesh/D007004" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hypoglycémiants - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hypoglycémiants", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hypoglycémiants", "description": "Comment diagnostiquer une hypoglycémie ?\nQuels tests sont utilisés pour le diabète ?\nQuels symptômes indiquent une hypoglycémie ?\nQuand consulter un médecin pour hypoglycémie ?\nQuel rôle joue l'HbA1c dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hypoglycémiants", "description": "Quels sont les signes d'une hypoglycémie ?\nComment reconnaître une hypoglycémie sévère ?\nLes symptômes varient-ils selon les personnes ?\nQuels symptômes nécessitent une intervention rapide ?\nLes symptômes peuvent-ils être confondus avec d'autres ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hypoglycémiants", "description": "Comment prévenir l'hypoglycémie ?\nQuel rôle joue l'exercice dans la prévention ?\nLes patients doivent-ils surveiller leur glycémie ?\nComment éduquer les patients sur l'hypoglycémie ?\nLes régimes alimentaires peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hypoglycémiants", "description": "Quels sont les principaux hypoglycémiants ?\nComment administrer du glucose en cas d'hypoglycémie ?\nQuels sont les effets secondaires des hypoglycémiants ?\nComment ajuster le traitement hypoglycémiant ?\nLes hypoglycémiants sont-ils efficaces pour tous ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hypoglycémiants", "description": "Quelles sont les complications de l'hypoglycémie ?\nL'hypoglycémie peut-elle entraîner des séquelles ?\nComment l'hypoglycémie affecte-t-elle la qualité de vie ?\nLes complications sont-elles réversibles ?\nQuels sont les risques à long terme de l'hypoglycémie ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hypoglycémiants", "description": "Quels sont les facteurs de risque d'hypoglycémie ?\nL'âge influence-t-il le risque d'hypoglycémie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il aggraver l'hypoglycémie ?\nLes médicaments peuvent-ils influencer le risque ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une hypoglycémie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'hypoglycémie est diagnostiquée par des tests de glycémie inférieure à 70 mg/dL." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diabète ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la glycémie à jeun, l'HbA1c et le test de tolérance au glucose." } }, { "@type": "Question", "name": "Quels symptômes indiquent une hypoglycémie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent tremblements, sueurs, confusion et palpitations." } }, { "@type": "Question", "name": "Quand consulter un médecin pour hypoglycémie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si les symptômes persistent ou s'aggravent." } }, { "@type": "Question", "name": "Quel rôle joue l'HbA1c dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'HbA1c évalue le contrôle glycémique sur 2-3 mois, utile pour le diagnostic du diabète." } }, { "@type": "Question", "name": "Quels sont les signes d'une hypoglycémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent fatigue, irritabilité, faim intense et vertiges." } }, { "@type": "Question", "name": "Comment reconnaître une hypoglycémie sévère ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une hypoglycémie sévère peut provoquer des convulsions, une perte de conscience ou un coma." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les personnes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier d'une personne à l'autre en fonction de la sensibilité." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une intervention rapide ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes graves comme confusion, convulsions ou perte de conscience nécessitent une aide immédiate." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être confondus avec d'autres ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être confondus avec ceux d'autres conditions comme l'anxiété ou l'AVC." } }, { "@type": "Question", "name": "Comment prévenir l'hypoglycémie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Prévenir l'hypoglycémie nécessite une alimentation équilibrée et un suivi régulier de la glycémie." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier aide à réguler la glycémie et à prévenir les épisodes d'hypoglycémie." } }, { "@type": "Question", "name": "Les patients doivent-ils surveiller leur glycémie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la surveillance régulière de la glycémie est essentielle pour prévenir l'hypoglycémie." } }, { "@type": "Question", "name": "Comment éduquer les patients sur l'hypoglycémie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation doit inclure la reconnaissance des symptômes et les mesures à prendre en cas d'hypoglycémie." } }, { "@type": "Question", "name": "Les régimes alimentaires peuvent-ils aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime alimentaire équilibré et riche en fibres peut aider à stabiliser la glycémie." } }, { "@type": "Question", "name": "Quels sont les principaux hypoglycémiants ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux hypoglycémiants incluent la metformine, les sulfonylurées et les inhibiteurs DPP-4." } }, { "@type": "Question", "name": "Comment administrer du glucose en cas d'hypoglycémie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le glucose peut être administré par voie orale ou intraveineuse selon la gravité." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des hypoglycémiants ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des nausées, des diarrhées et des hypoglycémies." } }, { "@type": "Question", "name": "Comment ajuster le traitement hypoglycémiant ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement doit être ajusté en fonction des niveaux de glycémie et des symptômes." } }, { "@type": "Question", "name": "Les hypoglycémiants sont-ils efficaces pour tous ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité peut varier selon le type de diabète et la réponse individuelle." } }, { "@type": "Question", "name": "Quelles sont les complications de l'hypoglycémie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques, des accidents vasculaires cérébraux et des chutes." } }, { "@type": "Question", "name": "L'hypoglycémie peut-elle entraîner des séquelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des épisodes répétés peuvent causer des dommages neurologiques permanents." } }, { "@type": "Question", "name": "Comment l'hypoglycémie affecte-t-elle la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'hypoglycémie fréquente peut entraîner une anxiété accrue et une diminution de la qualité de vie." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles si l'hypoglycémie est traitée rapidement." } }, { "@type": "Question", "name": "Quels sont les risques à long terme de l'hypoglycémie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les risques à long terme incluent des troubles cognitifs et une augmentation du risque cardiovasculaire." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'hypoglycémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent un traitement intensif du diabète, une alimentation irrégulière et l'alcool." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'hypoglycémie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de souffrir d'hypoglycémie en raison de la sensibilité accrue." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de diabète peuvent augmenter le risque d'hypoglycémie." } }, { "@type": "Question", "name": "Le stress peut-il aggraver l'hypoglycémie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affecter la glycémie et augmenter le risque d'hypoglycémie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils influencer le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments, comme les bêta-bloquants, peuvent masquer les symptômes d'hypoglycémie." } } ] } ] }

Sources (10000 au total)

Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.

This study investigated the demand for and awareness of a primary healthcare pilot project for people with disabilities; it also sought to identify relevant determinants for demand and awareness using... This study is a secondary analysis of data from the population-based survey conducted in Gyeonggi Regional Health & Medical Center for People with Disabilities. The data was designed with quota ra... Awareness of the service (12.1%) was remarkably low, while the demand (80.5%) was high. The gap between respondents who needed the service but were unaware of it differed according to age, education, ... Chronic disease and an unmet need for medical care were key determinants of service demand, while the severity of disability was not. Thus, there is a need to review the initiative that defines servic...

[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].

Communication and interprofessional collaboration with patients diagnosed with cancer is challenging. Structured communication training has not yet been integrated into postgraduate medical education.... A needs assessment was conducted using focus groups and individual interviews. Learning objectives were aligned with (inter)national learning objective catalogs. The ICT was developed using the six-st... Physician participation rates in the workshops were 83.0% and nursing participation rates were 58.3%. Utilization of the workplace-based training was 97%. The physicians evaluated the ICT very positiv... The implementation of an ICT with 80 teaching units is successfully feasible in a urological clinic and leads to a sustainable improvement of the communication culture, among other things through ment...

[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].

Analysis of psychiatric-psychotherapeutic crisis services in the Leipzig Psychiatry Network (LeiP#netz), assigning the services to the functional areas of the FBM according to Steinhart and Wienberg.... A standardized survey of crisis care was conducted using the functions "complex outpatient treatment", "access to acute psychotherapy in crisis", and "24 h complex, intensive treatment" by means of fa... A total of 31 measures were recorded for the three functions. All crisis care services were highly utilized; in up to one-third of cases, no services could be provided when demand was requested. Servi... Crisis care services for severely mentally ill people are available in various constellations in the study region. Low-threshold 24/7 crisis services need to be expanded....

Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.

Social determinants of health (SDOH) and stress during pregnancy may contribute to adverse pregnancy outcomes. The objective of this in the field pilot project was to develop a comprehensive screening... Pregnant patients accessing prenatal care at a single site of an urban Federally Qualified Health Center were recruited during prenatal visits to complete a Social Determinants of Health in Pregnancy ... Between April 2018 and March 2019, 135 pregnant participants completed SIPT. Ninety-one percent of patients scored positive on at least one screener, 54% to three or more screeners.... Despite guidelines to screen for SDOH during pregnancy there is no universal tool. Our pilot project demonstrated the concurrent use of adapted screening tools where participants reported at least one...

Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.

Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative feca... In this feasibility study, 7039 individuals aged 50-75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHW... Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested posi... Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healt...

Conducting two evidence syntheses in six weeks - experiences with and evaluation of a pilot project.

Evidence synthesis organisations are trying to meet commissioners' needs for rapid responses to their evidence synthesis commissions. In this project we piloted an intensive process, working to comple... In a pre-planning phase, an intensive work group was established, and two commissions were selected for this pilot project. The evidence synthesis process was divided into two phases: planning and int... During the planning phase, teams identified significant uncertainties regarding scopes, research questions, and inclusion criteria. To address this, they engaged with commissioners earlier than origin... Overall, the intensive process fostered focus and productivity, allowing teams to manage short-term deliverables effectively. The researchers preferred working intensively with one evidence synthesis ...

[Implementation of a Pilot Project Supporting Parents Suffering from Cancer with Underage Children].

Families with one parent suffering from cancer are exposed to extraordinary emotional and organizational burdens, affecting underaged children. To help coordinated access to social and logistic suppor... A cross-sectional observational study was conducted using a mixed-method approach. Semi-structured written expert surveys (n=10) and secondary analysis of routine data of the care model (n=171 familie... Quantitative secondary analysis: The participating families had 1-7 children (median (m) 2, range (s) 6). In 66% of the cases, the mother was affected by cancer, in 20% the diseased parent was in a si... The data collected indicate that in families, matching the German average in their socio-demographic characteristics, a great need for organizational support develops as soon as one parent becomes sic...

A pilot project of expert nurses for the follow-up of complex intravenous antimicrobial treatment.

To report a pilot project of expert nurses for outpatient parenteral antimicrobial treatment (OPAT) follow-up.... Three nurses with specific training on antibiotics started a state-funded programme including: i) consultations for OPAT follow-up; ii) hotline for satellite hospitals; iii) peer training. Patients' d... From December 2020 to December 2021, 118 patients (median age 66.5 years [52-75], male-to-female ratio 2.5) were enrolled, for a total of 621 consultations. Patients were mostly on OPAT for bone and j... Nurses may be important actors for OPAT follow-up....

Implementation of entrustable professional activities into fellowship council accredited programs: a pilot project.

The Fellowship Council (FC) is transitioning to a competency-based medical education (CBME) model, including the introduction of Entrustable Professional Activities (EPAs) for training and assessment ... The FC coordinated the development of EPAs in collaboration with the sponsoring societies for Advanced GI/MIS, Bariatrics, Foregut, Endoscopy and Hepatopancreaticobiliary (HPB) fellowships encompassin... The 15 participating programs included 18 fellows and 106 faculty. A total of 655 assessments were initiated with 429 (65%) completed. The average (SD) number of EPAs completed for each fellow was 24(... A competency-based assessment framework was developed by the FC and piloted in several programs. Participation was variable and required ongoing strategies to address barriers. The pilot project has p...